1 citations
,
June 2022 in “Journal of Plastic Reconstructive and Aesthetic Surgery”
This article discusses the high risk and stress associated with medical malpractice lawsuits against plastic surgeons, particularly in cosmetic procedures, but provides no new research results.
This article highlights various endocrine disorders and other etiologies linked to alopecia and emphasizes the importance of diagnosing treatable conditions before starting hair loss treatment.
This case report describes retinal occlusion and medial canthal swelling in a 64-year-old female following the injection of acellular porcine urinary bladder matrix for hairrestoration, a previously unreported side effect.
A 35-year-old male shared his hairrestoration journey, starting with minoxidil and finasteride, which improved his hairline and crown, followed by a hair transplant in November 2024. He stopped finasteride to conceive, experienced some shedding, and is now considering switching to dutasteride while continuing minoxidil.
David Barreto shared that a London-based research group is conducting a 12-month trial for a new nutraceutical treatment for pattern hair loss, designed with Dr. Carlos Puig. The trial aims to provide robust data, with results expected in 1-2 years, potentially representing a significant advancement since finasteride’s introduction in 1997.
Hairrestoration treatments like finasteride, minoxidil, dutasteride, and hair transplants can greatly enhance self-image and dating life. Opinions differ on whether to embrace baldness or pursue treatments for maintaining hair.
A US federal judge ruled that using patients' stem cells for medical treatments is not under FDA jurisdiction, potentially speeding up development of stem cell-based hair loss therapies. Some users are optimistic about increased research and development, while others express skepticism about the ruling's impact on safety and efficacy standards.
Pelage is moving to Phase III clinical trials for PP405, a hair loss treatment, with results to be presented at a medical meeting. Users express skepticism and hope, comparing it to existing treatments like Minoxidil and finasteride, while discussing the potential for new hair growth in previously bald areas.
Hair transplantation moves DHT-resistant follicles from a donor area (back and sides of the scalp) into thinning or bald areas. The transplanted hair is generally permanent, though surrounding native hair can keep thinning.